PPM1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.671000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.410200E-01
Normal-vs-Stage2
6.864200E-01
Normal-vs-Stage3
2.680600E-01
Normal-vs-Stage4
2.484400E-01
Stage1-vs-Stage2
7.196200E-01
Stage1-vs-Stage3
1.412010E-01
Stage1-vs-Stage4
3.394400E-01
Stage2-vs-Stage3
1.959810E-01
Stage2-vs-Stage4
8.754400E-02
Stage3-vs-Stage4
1.160610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.699000E-01
Normal-vs-AfricanAmerican
5.823600E-01
Normal-vs-Asian
9.932800E-01
Caucasian-vs-AfricanAmerican
7.510200E-01
Caucasian-vs-Asian
4.348200E-01
AfricanAmerican-vs-Asian
4.535800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.991600E-01
Normal-vs-Female
6.416000E-01
Male-vs-Female
8.472600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.503200E-01
Normal-vs-Age(41-60Yrs)
5.201000E-01
Normal-vs-Age(61-80Yrs)
7.171800E-01
Normal-vs-Age(81-100Yrs)
7.249000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.882200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.057400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.964800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.220400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.170300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.228000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.823800E-01
Normal-vs-Daily Drinker
8.246200E-01
Normal-vs-Weekly Drinker
9.400200E-01
Normal-vs-Occasional Drinker
3.364000E-01
Normal-vs-Social Drinker
6.038600E-01
Non Drinker-vs-Daily Drinker
8.647800E-01
Non Drinker-vs-Weekly Drinker
8.406600E-01
Non Drinker-vs-Occasional Drinker
1.111000E-01
Non Drinker-vs-Social Drinker
3.795000E-01
Daily Drinker-vs-Weekly Drinker
7.256800E-01
Daily Drinker-vs-Occasional Drinker
1.819800E-01
Daily Drinker-vs-Social Drinker
4.955400E-01
Weekly Drinker-vs-Occasional Drinker
7.734100E-02
Weekly Drinker-vs-Social Drinker
3.225600E-01
Occasional Drinker-vs-Social Drinker
6.561600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.826000E-01
Normal-vs-Grade 2
1.112390E-01
Normal-vs-Grade 3
6.538200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.850600E-01
Grade 1-vs-Grade 3
4.560800E-01
Grade 1-vs-Grade 4
2.826000E-01
Grade 2-vs-Grade 3
5.678600E-01
Grade 2-vs-Grade 4
1.112390E-01
Grade 3-vs-Grade 4
6.538200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.933400E-01
Normal-vs-NonDiabetic
7.631600E-01
Diabetic-vs-NonDiabetic
8.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.269600E-01
Normal-vs-NoPancreatitis
7.392600E-01
Pancreatitis-vs-NoPancreatitis
5.025400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.472200E-01
Normal-vs-N1
6.684200E-01
N0-vs-N1
6.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.186800E-01
Normal-vs-TP53-NonMutant
4.555600E-01
TP53-Mutant-vs-TP53-NonMutant
8.855600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
